Atrial fibrillation (AF), which is the name for rapid beats in the upper chambers of the heart, is the world's most common kind of irregular heart beat. People with AF experience symptoms such as heart palpitations (a racing or pounding feeling in the chest), shortness of breath, dizziness, fatigue or weakness. Although AF can occur in otherwise healthy people for no apparent reason, it is sometimes associated with high blood pressure, heart disease or lung problems. The purpose of the SAFARI trial is to study the effectiveness of pacing algorithms in the upper chamber of the heart for patients who have both AF and bradycardia (slow heart beat).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
540
Unnamed facility
Yuma, Arizona, United States
Unnamed facility
Fayetteville, Arkansas, United States
Unnamed facility
Fort Smith, Arkansas, United States
Unnamed facility
Bakersfield, California, United States
Unnamed facility
Berkeley, California, United States
Unnamed facility
Los Angeles, California, United States
Unnamed facility
Aurora, Colorado, United States
Unnamed facility
Stamford, Connecticut, United States
Unnamed facility
Clearwater, Florida, United States
Unnamed facility
Daytona Beach, Florida, United States
...and 24 more locations
Safety/Efficacy
Various
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.